Skip to main content

Advertisement

SpringerLink
Log in

Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Curigliano G, Balduzzi A, Cardillo A et al (2007) Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Support Care Cancer 15:1213–1217

    Article  PubMed  Google Scholar 

  2. Bern MM, Lokich JJ, Wallach SR et al (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423–428

    PubMed  CAS  Google Scholar 

  3. Monreal M, Alaustrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices. Profilaxis with low molecular weight heparin (Fragmin). Profilaxis with low molecular weight heparin (Fragmin). Thromb Haemost 75:251–253

    PubMed  CAS  Google Scholar 

  4. Reichardt P, Kretzschmar A, Biakhov M et al (2002) A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight-heparin (dalteparin sodium) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Proc Am Soc Clin Oncol 21:369a

    Google Scholar 

  5. Mismetti P, Mille D, Laporte S et al (2003) Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremiy thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88:67–73

    PubMed  CAS  Google Scholar 

  6. Couban S, Goodyear M, Burnell M et al (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23:4063–4069

    Article  PubMed  CAS  Google Scholar 

  7. Verso M, Agnelli G, Bertoglio S et al (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23:4057–4062

    Article  PubMed  CAS  Google Scholar 

  8. Karthaus M, Kretzschmar A, Kronig H et al (2006) Deltaparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17:289–296

    Article  PubMed  CAS  Google Scholar 

  9. Randolph AG, Cook DJ, Gonzales CA et al (1998) Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113:165–171

    Article  PubMed  CAS  Google Scholar 

  10. Klerk CPW, Smorenburg SM, Buller HR (2003) Thrombosis prophylaxis in patient populations with central venous catheter. Arch Intern Med 163:1913–1921

    Article  PubMed  Google Scholar 

  11. Geerts WH, Heit JA, Clagett GP et al (2001) Prevention of venous thromboembolism. Chest 119:132–175

    Article  Google Scholar 

  12. Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21:3665–3675

    Article  PubMed  Google Scholar 

  13. Nicolaides AN, Fareed J, Kakkar AK et al (2006) Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 25:101–161

    Google Scholar 

  14. Orlando L, Colleoni M, Nolè F et al (2000) Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required? Ann Oncol 11:117–118

    Article  PubMed  CAS  Google Scholar 

  15. Hovens MMC, Snoep JD, Tamsma JT et al (2006) Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost 4:1470–1475

    Article  PubMed  CAS  Google Scholar 

  16. Verso M, Agnelli G, Kamphuisen PW et al (2006) Risk factors for CVC-associated thrombosis in cancer patients: analysis of the ETHIC study. Haematologica 91(supplement 2):84

    Google Scholar 

  17. Lee AYY, Levine MN, Butler G et al (2006) Incidence, risk factor, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404–1408

    Article  PubMed  Google Scholar 

  18. Mandalà M, Curigliano G, Bucciarelli P et al (2004) Farctor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 15:590–593

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Supportive and Palliative Care Unit, Department of Oncology, City Hospital, c.p.n. 35, 47822 Santarcangelo di Romagna (RN), Rimini, Italy

    Davide Tassinari & Carlotta Santelmo

  2. Department of Internal Medicine, Arcispedale S. Anna, Ferrara, Italy

    Paola Tombesi & Sergio Sartori

Authors
  1. Davide Tassinari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlotta Santelmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Tombesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sergio Sartori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Davide Tassinari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tassinari, D., Santelmo, C., Tombesi, P. et al. Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know. Support Care Cancer 16, 311–312 (2008). https://doi.org/10.1007/s00520-007-0385-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0385-x

Keywords

Search

Navigation